Gordon C. Weir

Active 1973–2025

133
Papers
29,585
Citations
101
h-index
132
i10-index

Citations

Citations per year for Gordon C. Weir1974: 3 citations1975: 2 citations1976: 10 citations1977: 7 citations1978: 15 citations1979: 6 citations1980: 4 citations1981: 14 citations1982: 18 citations1983: 14 citations1984: 14 citations1985: 15 citations1986: 40 citations1987: 35 citations1988: 30 citations1989: 28 citations1990: 47 citations1991: 55 citations1992: 45 citations1993: 53 citations1994: 65 citations1995: 73 citations1996: 69 citations1997: 82 citations1998: 79 citations1999: 95 citations2000: 116 citations2001: 180 citations2002: 239 citations2003: 222 citations2004: 246 citations2005: 250 citations2006: 251 citations2007: 235 citations2008: 204 citations2009: 278 citations2010: 276 citations2011: 207 citations2012: 218 citations2013: 251 citations2014: 202 citations2015: 190 citations2016: 228 citations2017: 258 citations2018: 226 citations2019: 684 citations2020: 687 citations2021: 822 citations2022: 503 citations2023: 377 citations2024: 588 citations2025: 255 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,972 citing papers, 32.3% of this breakdownChina: 752 citing papers, 8.2% of this breakdownUnited Kingdom: 498 citing papers, 5.4% of this breakdownCanada: 470 citing papers, 5.1% of this breakdownGermany: 400 citing papers, 4.4% of this breakdownJapan: 346 citing papers, 3.8% of this breakdownItaly: 303 citing papers, 3.3% of this breakdownSwitzerland: 279 citing papers, 3% of this breakdownSweden: 260 citing papers, 2.8% of this breakdownFrance: 257 citing papers, 2.8% of this breakdownAustralia: 238 citing papers, 2.6% of this breakdownDenmark: 208 citing papers, 2.3% of this breakdown
0%32.3%Other 24%

Fields

  • Medicine67.9%
  • Biochemistry, Genetics and Molecular Biology19.8%
  • Engineering3.6%
  • Neuroscience3.1%
  • Immunology and Microbiology1.4%
  • Materials Science1.4%
  • Other2.8%

Topics

  • Pancreatic function and diabetes17.5%
  • Diabetes and associated disorders7.7%
  • Diabetes Management and Research5.3%
  • Metabolism, Diabetes, and Cancer3.9%
  • Diabetes Treatment and Management3.8%
  • Pluripotent Stem Cells Research2.9%
  • Other58.9%

Coauthors

All papers

Open in search
  1. Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Materials 2015 cited by 884

  2. Acceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes

    Authors: , , , , , , , , , - Cell Metabolism 2019 cited by 446

  3. Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dale L. Greiner, José Oberholzer, Gordon C. Weir, Róbert Langer, Daniel G. Anderson - Nature Biotechnology 2016 cited by 547

  4. Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biomedical Engineering 2018 cited by 355

  5. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.

    Authors: , , - Journal of Clinical Investigation 1987 cited by 871

  6. Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 cited by 690

  7. Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes

    Authors: , - Diabetes 2004 cited by 1,107

  8. A retrievable implant for the long-term encapsulation and survival of therapeutic xenogeneic cells

    Authors: , , , , , , , , , , , , , , , - Nature Biomedical Engineering 2020 cited by 171

  9. Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Materials 2019 cited by 178

  10. Glucolipotoxicity, β-Cells, and Diabetes: The Emperor Has No Clothes

    Authors: - Diabetes 2019 cited by 168

  11. β Cell Aging Markers Have Heterogeneous Distribution and Are Induced by Insulin Resistance

    Authors: , , , , , , , , , , , , - Cell Metabolism 2017 cited by 202

  12. Injectable and Glucose-Responsive Hydrogels Based on Boronic Acid–Glucose Complexation

    Authors: , , , , , , , , , , - Langmuir 2016 cited by 182

  13. Induced Pluripotent Stem Cells Generated Without Viral Integration

    Authors: , , , , - Science 2008 cited by 1,661

  14. Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug

    Authors: , , , , , , , , , , , , , - Biomaterials 2013 cited by 127

  15. Gene Expression Profiles of Beta-Cell Enriched Tissue Obtained by Laser Capture Microdissection from Subjects with Type 2 Diabetes

    Authors: , , , , , , , - PLoS ONE 2010 cited by 319

  16. C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph A. Hedrick, Johnny Ludvigsson, Matthias von Herrath, Francisco James León Trujillo, Eleanor L. Ramos, Parth Narendran, Stephen E. Gitelman, Dana Dabelea, Robert Andrews, Michael J. Haller, Elizabeth T. Jensen, Kevan Harold, Jan Dutz - The Lancet Diabetes & Endocrinology 2023 cited by 56

  17. Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes

    Authors: , , - The Lancet Diabetes & Endocrinology 2020 cited by 196

  18. Human Islet Morphology Revisited

    Authors: , , - Journal of Histochemistry & Cytochemistry 2015 cited by 132

  19. Chronic Hyperglycemia Triggers Loss of Pancreatic β Cell Differentiation in an Animal Model of Diabetes

    Authors: , , , , , , , - Journal of Biological Chemistry 1999 cited by 560

  20. β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment

    Authors: , , , , , , , , , - Diabetes Care 2014 cited by 465

  21. Identification of a humanized mouse model for functional testing of immune-mediated biomaterial foreign body response

    Authors: , , , , , , , , , , , , , , , , , , - Science Advances 2023 cited by 24

  22. Increased Interleukin (IL)-1β Messenger Ribonucleic Acid Expression in β-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1β in Human Islets by Glucose and Autostimulation

    Authors: , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2008 cited by 320

  23. Islet β cell mass in diabetes and how it relates to function, birth, and death

    Authors: , - Annals of the New York Academy of Sciences 2013 cited by 293

  24. Downregulation of GLP-1 and GIP Receptor Expression by Hyperglycemia

    Authors: , , , , , , , , - Diabetes 2007 cited by 368